Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 176
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others

EDITORIAL

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?

Ahmad Akram, Khan Muhammad Umair, Patel Isha

Year : 2015| Volume: 4| Issue : 1 | Page no: 1-3

   This article has been cited by
 
1 Importance of Evidence-Based Health Insurance Reimbursement and Health Technology Assessment for achieving Universal Health Coverage and Improved Access to Health in India
Amit Dang,Dimple Dang,B.N. Vallish
Value in Health Regional Issues. 2021; 24: 24
[Pubmed]  [Google Scholar] [DOI]
2 Assessment of Patients Misunderstanding of Dosing Instructions Among Outpatients in Dessie Referral Hospital, Northeast Ethiopia
Yohannes Mengesha,Eskedar Amare
Risk Management and Healthcare Policy. 2020; Volume 13: 3079
[Pubmed]  [Google Scholar] [DOI]
3 Burden of out-of-pocket health expenditure and its impoverishment impact in India: evidence from National Sample Survey
Shivendra Sangar,Varun Dutt,Ramna Thakur
Journal of Asian Public Policy. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
4 BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management
Victor G. Rodwin,Guilhem Fabre,Rafael F. Ayoub
International Journal of Health Policy and Management. 2018; 7(3): 201
[Pubmed]  [Google Scholar] [DOI]
5 The Road to Addressing Noncommunicable Diseases and Cancer in Global Health Policy
Heath Catoe,Jordan Jarvis,Sudeep Gupta,Ophira Ginsburg,Gilberto de Lima Lopes
American Society of Clinical Oncology Educational Book. 2017; (37): 29
[Pubmed]  [Google Scholar] [DOI]

 

Read this article